The chin profile may be compromised due to the presence of excess submental fat. This can make the neck and lower face appear older and unsightly. Many people seek the reduction of double chin appearance through plastic surgery.
However, now an innovative non-surgical treatment called Kybella is available, which can help reduce double chin. Dr. Gary Motykie is a leading cosmetic surgeon providing this cutting edge non-surgical technology to his patients in Beverly Hills, West Hollywood, Los Angeles, and surrounding communities.
Kybella or ATX-101 from Kythera is a unique treatment that does not involve plastic surgery to treat double chin, which is caused due to excessive submental fat tissue. The FDA has now approved Kybella treatment. With this approval, Kybella becomes the first and only non-surgical treatment to have an FDA approval for the reduction of double chin.
Keith Leonard, President and CEO of Kythera, says that Kybella is a fantastic and salient solution that can be tailored to meet the unique aesthetic goals of a patient for an enhanced chin profile. Higher rates of patient satisfaction are typically achieved because of the non-invasive nature of Kybella treatment.
Leonard says: “For the first time, people have access to an FDA-approved, non-surgical treatment for submental fullness, a condition that can negatively impact the overall appearance of the face and can result in a person feeling older and heavier. With Kybella, physicians can offer a clinically-proven treatment that is customized to the patient and their treatment goals for an improved chin profile.”
As a leading cosmetic surgeon, Dr. Gary Motykie supports the latest, proven and FDA approved cutting edge treatments designed to enhance a person’s appearance. Dr. Motykie provides state of the art surgical and non-surgical cosmetic procedures to patients in Beverly Hills, West Hollywood, Los Angeles, and nearby areas.
Kybella’s success is backed by an international clinical development program that covered more than 20 clinical studies and 2,600 patients worldwide. In the pivtal Phase III studies, more than 68% patients indicated a favorable response to Kybella. They report improvements in the amount of fat in the area underneath the chin. The emotional benefits achieved due to submental fat reduction were also enumerated by the patients.
Kybella treatment is administered through injections directly into the specific fatty tissue below the chin. The treatment program will be customized according to the unique condition of the patient. One treatment session will typically last for about 20 minutes. Two to four treatments are usually required to achieve visible results. A maximum of six treatments of Kybella may be administered as the patient’s needs.
Dr. Michael C. Edwards, the President of the American Society for Aesthetic Plastic Surgery (ASAPS), says that Kybella is an excellent revolution with prolific potential for the aesthetics industry. Dr. Edwards says it is critically important to choose the right surgeon to receive an advanced injectable solution such as Kybella.
The advantage with Kybella is that the procedure avoids all the typical risks and complications that may be associated with a surgery. The downtime is minimal and the patient does not have to undergo a prolonged treatment or recovery process.
To see more services and treatments provided by Plastic Surgeon, Dr. Motykie in Beverly Hills | Los Angeles and his team please visit: